✦ LIBER ✦

Safety, pharmacokinetics and pharmacodynamics of the anti-A33 fully-human monoclonal antibody, KRN330, in patients with advanced colorectal cancer

✍ Scribed by Infante, Jeffrey R.; Bendell, Johanna C.; Goff, Laura Williams; Jones, Suzanne F.; Chan, Emily; Sudo, Tomohiro; Burris, Howard A.; Berlin, Jordan D.

Book ID: 122561971
Publisher: Elsevier Science
Year: 2013
Tongue: English
Weight: 511 KB
Volume: 49
Category: Article
ISSN: 0959-8049
DOI: 10.1016/j.ejca.2012.11.033

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase 1/2 study of KRN330, a fully human

Phase 1/2 study of KRN330, a fully human anti-A33 monoclonal antibody, plus irinotecan as second-line treatment for patients with metastatic colorectal cancer

✍ Bendell, Johanna C.; Lenz, Heinz-Josef; Ryan, Theresa; El-Rayes, Bassel F.; Mars 📂 Article 📅 2014 🏛 Springer US 🌐 English ⚖ 223 KB

Safety, Tolerability, Pharmacokinetics,

Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Anti-TWEAK Monoclonal Antibody in Patients With Rheumatoid Arthritis

✍ Wisniacki, Nicolas; Amaravadi, Lakshmi; Galluppi, Gerald R.; Zheng, Timothy S.; 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 347 KB

Phase I safety, pharmacokinetic and phar

Phase I safety, pharmacokinetic and pharmacodynamic study of recombinant human anti-VEGF antibody HuMV833 in patients with advanced cancer

📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 140 KB

1201 ORAL Early Studies of the Safety, P

1201 ORAL Early Studies of the Safety, Pharmacokinetics (PK), Pharmacodynamics (PD), and Anti-tumour Activity of the Humanized Monoclonal Antibody (huMAb) Anti-EGFL7 (MEGF0444A) Alone and in Combination With Bevacizumab (Bev) With and Without Paclitaxel (Pac) in Patients (pts) With Advanced Cancer

✍ L. Rosen; P. Munster; S. Bai; P. Hegde; J. Fredrickson; R. Funke; I. Chang; D. C 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 44 KB

Safety, pharmacokinetics, and pharmacody

Safety, pharmacokinetics, and pharmacodynamics of the DR5 antibody LBY135 alone and in combination with capecitabine in patients with advanced solid tumors

✍ Sharma, Sunil; Vries, Elisabeth G.; Infante, Jeffrey R.; Oldenhuis, Corina N.; G 📂 Article 📅 2013 🏛 Springer US 🌐 English ⚖ 523 KB

Single-dose pharmacokinetics and safety

Single-dose pharmacokinetics and safety of HA-1A, a human IgM anti-lipid-A monoclonal antibody, in pediatric patients with sepsis syndrome

✍ Michael J. Romano; Gregory L. Kearns; Sheldon L. Kaplan; Richard F. Jacobs; Anth 📂 Article 📅 1993 🏛 Elsevier Science 🌐 English ⚖ 765 KB